Trial intelligence / Profile preview

Dexmedetomidine for Renal Protection in Radical Cystectomy

NCT03265470Completed

Sponsor
Mansoura University
Start
Dec 2015
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in acute kidney injury (AKI) (2 arms), sponsored by Mansoura University. Primary endpoint: Serum cystatin C level at 24 hours. Started Dec 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT03265470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03265470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call